Stock CIPI CORRELATE ENERGY CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Correlate Energy Corp.

Equities

CIPI

US89609L1017

Biotechnology & Medical Research

Market Closed - OTC Markets
Other stock markets
 09:41:55 08/05/2024 pm IST 		5-day change 1st Jan Change
1.246 USD -0.08% Intraday chart for Correlate Energy Corp. -4.15% -11.00%
01/04 Correlate Energy Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
07/02 Correlate Energy Corp. Announces Strategic Partnership with Carbonsight CI

Valuation

Fiscal Period: December 2020 2021 2022 2023
Capitalization 1 30 37.95 37.44 50.68
Enterprise Value (EV) 1 30 37.75 39.23 52.88
P/E ratio -246 x -606 x -5.17 x -3.94 x
Yield - - - -
Capitalization / Revenue - 38,54,90,523 x 1,10,00,856 x 67,00,750 x
EV / Revenue - 38,34,40,780 x 1,15,27,301 x 69,92,018 x
EV / EBITDA - - -71,21,471 x -88,63,308 x
EV / FCF 17,42,70,931 x 14,79,62,571 x 8,19,09,116 x 8,78,89,850 x
FCF Yield 0% 0% 0% 0%
Price to Book -109 x 88.1 x -13.3 x -16 x
Nbr of stocks (in thousands) 1,00,000 34,500 35,324 36,198
Reference price 2 0.3000 1.100 1.060 1.400
Announcement Date 20/07/21 14/04/22 31/03/23 01/04/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023
Net sales - - 0.0984 3.404 7.563
EBITDA - - - -5.509 -5.966
EBIT 1 -0.0892 -0.1162 -0.0752 -5.577 -6.217
Operating Margin - - -76.44% -163.87% -82.2%
Earnings before Tax (EBT) 1 -0.0892 -0.1062 -0.0902 -7.163 -12.79
Net income 1 -0.0892 -0.1062 -0.0902 -7.163 -12.79
Net margin - - -91.67% -210.45% -169.09%
EPS 2 -0.006235 -0.001219 -0.001815 -0.2049 -0.3551
Free Cash Flow - 0.1721 0.2551 0.479 0.6017
FCF margin - - 259.15% 14.07% 7.96%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 20/07/21 20/07/21 14/04/22 31/03/23 01/04/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023
Net Debt 1 - - - 1.79 2.2
Net Cash position 1 0.03 0 0.2 - -
Leverage (Debt/EBITDA) - - - -0.3252 x -0.3692 x
Free Cash Flow - 0.17 0.26 0.48 0.6
ROE (net income / shareholders' equity) - 76.2% 157% 604% 427%
ROA (Net income/ Total Assets) - -466% -6.14% -188% -114%
Assets 1 - 0.0228 1.471 3.816 11.22
Book Value Per Share 2 -0 -0 0.0100 -0.0800 -0.0900
Cash Flow per Share 2 0 0 0.0100 0 0.0400
Capex - - - 0 0.14
Capex / Sales - - - 0.14% 1.82%
Announcement Date 20/07/21 20/07/21 14/04/22 31/03/23 01/04/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
CORRELATE ENERGY CORP. Stock Correlate Energy Corp.
-11.00% 50.03M
MODERNA, INC. Stock Moderna, Inc.
+22.56% 46.4B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-1.51% 41.75B
LONZA GROUP AG Stock Lonza Group AG
+48.83% 41.37B
CELLTRION, INC. Stock Celltrion, Inc.
-3.42% 29.71B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+10.13% 26.01B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-20.44% 19.52B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+26.45% 12.43B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-0.14% 12.18B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-0.47% 12.13B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. CIPI Stock
  4. Financials Correlate Energy Corp.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW